<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2102221746
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1999
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        JUSPRIN 81MG ENTERIC COATED TABLETS
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        ACETYLSALICYLIC ACID
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        81
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Enteric-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        OTC
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        7.50
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Gulf Pharmaceutical Industries (Julphar)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Gulf Pharmaceutical Industries (Julphar)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 359]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Cigalah Group
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Gulf Pharmaceutical Industries (Julphar)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        N02BA01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        B01AC06
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong><u>What the medicinal ingredient is:</u></strong></p><p>Acetylsalicylic Acid (aspirin)</p><p><strong><u>What dosage forms it comes in:</u></strong></p><p><strong>Jusprin 81 </strong>comes as enteric-coated tablets, 81 mg.</p><p><strong><u>What the medication is used for:</u></strong></p><p>- <strong>Jusprin 81 </strong>is for doctor-supervised long-term preventive therapy.</p><p>- <strong>Jusprin 81</strong>may help save your life if you think you are having a heart attack.</p><p><strong><u>What it does:</u></strong></p><p><strong>Jusprin 81 </strong>is for doctor-supervised long-term preventative therapy.</p><p><strong>USE DURING A HEART ATTACK</strong></p><p>If you think you are having a heart attack, call hospital emergency department immediately then, chew or crush and swallow two <strong>Jusprin 81 </strong>tablets. It is important to chew or crush the product, to ensure this medicine works quickly. Then get to a hospital immediately for medical attention.</p><p>Inform the emergency services / hospital that you have taken <strong>Jusprin 81</strong>.</p><p>Taking <strong>Jusprin 81</strong>, at the first signs and symptoms can reduce your risk of dying from a heart attack.</p><p><strong>The signs and symptoms of a heart attack include: </strong></p><p>&bull; uncomfortable pressure, fullness, squeezing or pain in the centre of the chest that lasts more than a few minutes, or goes away quickly and comes back</p><p>&bull; pain that spreads to the shoulders, neck or arms</p><p>&bull; chest discomfort with light headedness, fainting, sweating, nausea or shortness of breath.</p><p>Chest pain is the most common symptom in both sexes, but women may also experience other symptoms such as unusual fatigue that gets worse with activity, difficulty of breathing, heartburn/nausea and /or vomiting unrelieved by antacids, tightening and pain in the chest that may extend into the neck, jaws and shoulders, general feeling of weakness, paleness, sweating)</p><p>At the hospital, the doctor will then recommend appropriate therapy.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>When it should not be used:</strong></p><p><strong>DO NOT TAKE if you:</strong></p><p>&bull; are allergic to aspirin, salicylates, non-steroidal anti- inflammatory drugs (NSAIDs)/pain relievers/fever reducers or other ingredients in the product</p><p>&bull; have an ulcer, history of ulcers or are prone to bleeding</p><p>&bull; have active or severe liver or kidney disease or congestive heart failure</p><p>&bull; have a history of asthma caused by salicylates or other NSAIDs</p><p>&bull; are using methotrexate at doses of 15 mg/week or more</p><p>&bull; are in the last trimester of pregnancy because it may cause problems to the unborn child or complications during delivery.</p><p><strong>Warnings and Precautions </strong></p><p>Your doctor will have asked you many questions about your health, lifestyle, and medications before recommending <strong>Jusprin 81</strong>.That is why it is very important that you tell your doctor all such information. If you have forgotten to tell your doctor about any of the following, call your doctor or pharmacist before you take this medicine (or any medicine):</p><p>&bull;&nbsp;&nbsp;&nbsp; asthma, high blood pressure, heart disease, gout or other serious conditions</p><p>&bull;&nbsp;&nbsp;&nbsp; age 60 years or older</p><p>&bull;&nbsp;&nbsp;&nbsp; stomach problems such as heartburn</p><p><strong>STOMACH BLEEDING WARNING: contains a NSAID which may cause severe stomach bleeding</strong></p><p>&bull;&nbsp;&nbsp;&nbsp; impaired liver/kidney or impaired cardiovascular circulation (renal vascular disease, congestive heart failure, volume depletion, major surgery, sepsis or major hemorrhagic events)</p><p>&bull;&nbsp;&nbsp;&nbsp; history of blood clotting defects</p><p>&bull;&nbsp;&nbsp;&nbsp; severe anemia</p><p>&bull;&nbsp;&nbsp;&nbsp; severe glucose-6-phosphate dehydrogenase (G6PD) deficiency</p><p>&bull;&nbsp;&nbsp;&nbsp; are trying to conceive, pregnant or breast-feeding or</p><p>&bull;&nbsp;&nbsp;&nbsp; will be having surgery in five to seven days.</p><p><strong>CAUTION: </strong>Contains enough drug to seriously harm a child.</p><p><strong>KEEP OUT OF REACH AND SIGHT OF CHILDREN. DO NOT GIVE </strong>to children/teenagers less than 18 years of age who have chicken pox or cold/flu symptoms before a doctor is consulted about Reye&rsquo;s Syndrome, a rare but serious illness reported to be associated with aspirin.</p><p><strong>Interactions with this medication</strong></p><p>Tell your doctor if you are taking any prescription or nonprescription drugs including blood thinners, acetaminophen, anticonvulsants, anti-diabetic/arthritis/gout medicines, digoxin, glucocorticoids, methotrexate, selective-serotonin re-uptake inhibitors (a type of antidepressant), diuretics, ACE inhibitors (medication for high blood pressure), or if you are having 3 or more alcoholic drinks per day.</p><p>Do not use ibuprofen if you are taking <strong>Jusprin 81 </strong>for preventive therapy without talking to a doctor or pharmacist. NSAIDs (i.e. ibuprofen or naproxen) may interfere with the preventive benefits of of <strong>Jusprin 81</strong>.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&nbsp;Always take <strong>Jusprin 81 </strong>exactly as your doctor has told you to. You should check with your doctor or pharmacist if you are not sure.</p><p><strong><u>Usual dose:</u></strong></p><p><strong>DIRECTIONS (Adults &ge; 18 years): For doctor-supervised long-term preventive therapy:</strong> 1 to 4 tablets daily, depending on your doctor&rsquo;s instructions. You should take this medicine at the same time every day. This will help you to remember to take your medication. For maximum effectiveness, it is very important to take <strong>Jusprin 81 </strong>every day as directed by your doctor. Do not take more tablets than your doctor recommends. Your doctor may tell you to take <strong>Jusprin 81 </strong>with other medications; he or she may also tell you to eat special foods, exercise or take other steps to safeguard your health. <strong>Jusprin 81 </strong>tablets have a special enteric coating, which allows them to pass undissolved through the stomach and into the intestine. By dissolving in the intestine rather than the stomach, the risk of stomach upset is reduced. Therefore, to maintain this protection, the tablets should not be crushed or broken.</p><p><strong><u>During a heart attack:</u></strong> Call hospital emergency department immediately, then, crush or chew 2 tablets.</p><p><strong>Can I continue to take Jusprin 81 for relief of headache, fever or arthritis pain? </strong></p><p><strong>Jusprin 81</strong> is specially designed for doctor supervised long-term preventive therapy. It is a smaller dose than you would need to take for a headache or other types of pain and is unlike other pain reliever products such as acetaminophen or NSAIDs e.g., ibuprofen, naproxen. Ask your doctor or pharmacist about other aspirin products available (or other pain relievers such as acetaminophen, ibuprofen, naproxen or salicylates) and the correct dosage for the relief of your headache, fever or arthritic pain.</p><p>Always consult with your doctor or pharmacist before taking other medications.</p><p><strong>Overdose:</strong></p><p>If you have taken too much <strong>Jusprin 81</strong>, contact your healthcare professional or hospital emergency department immediately, even if there are no symptoms.</p><p><strong>Missed dose:</strong></p><p>If you forget to take your medication, take it when you remember.</p><p>But do not take extra medication to compensate for a missed dosage unless instructed by your doctor.</p><p><strong>If you have any further questions on the use of this product, ask your doctor or pharmacist.</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, <strong>Jusprin 81 </strong>may occasionally produce unwanted side effects. You should call your doctor if you experience: nausea, vomiting; stomach irritation, or pain; if you notice that you are &lsquo;bruising&rsquo; more easily than you were before starting a daily dose of <strong>Jusprin 81</strong>. Regular daily use of alcohol while on <strong>Jusprin 81 </strong>daily therapy may increase your risk of developing gastrointestinal bleeding.</p><p>This is not a complete list of side effects. For any unexpected effects while taking <strong>Jusprin 81</strong>, contact your doctor or pharmacist.</p><p><strong>Serious side effects, how often they happen and what to do about them</strong></p><p>Stop use and call your doctor if you experience an allergic reaction (skin rash, hives, itching, swelling of eyes, face, lips, tongue, or throat, wheezing or breathing difficulties); stomach bleeding (feel faint, bloody vomit, vomit that looks like coffee grounds, bright red blood in stools, black or tarry stools, stomach pain that does not get better); loss of hearing, ringing or buzzing in ears, or bleeding.</p><p><strong><u>Reporting of side effects</u></strong></p><p>If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via:</p><p>&sect; <strong>Saudi Arabia:</strong></p><p><strong>The National Pharmacovigilance Centre (NPC):</strong></p><p>- <strong>SFDA Call Centre:</strong> 19999</p><p>- <strong>E-mail:</strong> npc.drug@sfda.gov.sa</p><p>- <strong>Website:</strong> https://ade.sfda.gov.sa</p><p>&sect; <strong>Other GCC States: </strong></p><p>- Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>-&nbsp; Keep out of the reach and sight of children.</p><p>-&nbsp; Do not take <strong>Jusprin 81 </strong>after the expiry date which is stated on the carton and label.</p><p>-&nbsp; Store below 30&deg;C, in a dry place.</p><p>After opening: use within 30 days.</p><p>-&nbsp; Do not take <strong>Jusprin 81 </strong>if you notice any visible sign of deterioration.</p><p>-&nbsp; Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What Jusprin 81 contains</strong></p><p>The active substance is aspirin. Each enteric-coated tablet contains 81mg of aspirin.</p><p><strong>Excipients:</strong> Microcrystalline cellulose, Maize Starch, Croscarmellose sodium, Colloidal Silicon Dioxide, Stearic Acid, Opadry Clear, Acryl eze, Triethyl citrate, Ethanol 95% and Simethicone antifoam.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Jusprin 81 enteric-coated tablets are available in packs of 30 or 90 tablets (in HDPE bottle).


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&nbsp;</p><p>&quot;الخليج للصناعات الدوائية&quot; جلفار</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                
08/09/2022

            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL"><strong><u>ما هي المادة الدوائية:</u></strong></p><p dir="RTL">حمض الأسيتيل سالسيليك (الأسبرين).</p><p dir="RTL"><strong><u>ما هو الشكل الصيدلاني المتوفر لدواء&nbsp; جوسبرين 81:</u></strong></p><p dir="RTL">يتوفر <strong>جوسبرين 81</strong> على هيئة أقراص ذات كسوة معوية، 81 ملغم.</p><p dir="RTL"><strong><u>ماهي دواعي استعمال </u></strong><strong><u>جوسبرين 81: </u></strong></p><p dir="RTL">&bull;&nbsp;&nbsp; يتم استخدام <strong>جوسبرين 81</strong> كعلاج وقائي طويل الأمد تحت إشراف الطبيب المعالج.</p><p dir="RTL">&bull;&nbsp;&nbsp; قد يساعد <strong>جوسبرين 81 </strong>في الحفاظ على حياتك في حال كنت تعتقد أنك تعاني من نوبة قلبية.</p><p dir="RTL"><strong>استخدام الدواء أثناء التعرض للنوبة قلبية</strong></p><p dir="RTL">إذا كنت تعتقد أنك تعاني من نوبة قلبية، يجب عليك الاتصال بقسم الطوارئ والإسعافات في المستشفى على الفور ثم قم بمضغ أو سحق قرصين من <strong>جوسبرين 81 </strong>ثم بلعهم<strong>.</strong> من المهم أن تقوم بمضغ أو سحق هذا الدواء لضمان سرعة الحصول على تأثيره الفعال. ثم توجه على الفور للحصول على الرعاية الطبية. يجب عليك إخبار الطاقم الطبي في المستشفى أنك قد تناولت <strong>جوسبرين 81. إ</strong>ن تناول <strong>جوسبرين 81</strong> عند ظهور أولى علامات وأعراض النوبة القلبية قد يقلل من خطر حدوث الوفاة.</p><p dir="RTL"><strong>تشمل أعراض وعلامات النوبة القلبية على:</strong></p><p dir="RTL">&bull;&nbsp;&nbsp; الشعور الغير مريح بالضغط والثقل، الامتلاء، ضغط أو ألم في منتصف الصدر يستمر لأكثر من عدة دقائق أو قد يختفي بسرعة ثم يعاود الحدوث مرة أخرى.</p><p dir="RTL">&bull;&nbsp;&nbsp; الشعور بالألم يمتد وينتشر في الكتفين، الرقبة أو الذراعين.</p><p dir="RTL">&bull;&nbsp;&nbsp; الشعور بعدم الراحة&nbsp; في الصدر مصحوباً بدوار، إغماء، تعرق، غثيان أو ضيق في التنفس.</p><p dir="RTL">يعد الشعور بألم الصدر، من الأعراض الأكثر شيوعاً لدى كلا الجنسين من الرجال والنساء، ولكن قد تعاني النساء أيضاً من أعراض أخرى على سبيل المثال شعور غير معتاد بالتعب والذي قد يزداد سوءاً مع القيام بأي نشاط أو مجهود، صعوبة التنفس، حرقة المعدة / غثيان و/أو قيء لا يزول بتناول مضادات الحموضة، شعور بالشد (ضيق) والألم في الصدر قد ينتشر ويمتد إلى الرقبة، الفكين والكتفين، شعور عام بالضعف، شحوب وتعرق. في المستشفى، سوف يوصي الطبيب بالعلاج المناسب.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>يجب عليك عدم تناول جوسبرين 81 في الحالات التالية:</strong></p><p dir="RTL">&bull;&nbsp;&nbsp; إذا كنت تعاني من الحساسية تجاه أسبرين، الساليسيلات، الأدوية الغير الستيرويدية المضادة للالتهابات، مسكنات الألم، خافضات الحرارة أو تجاه أياً من المكونات الأخرى في هذا الدواء.</p><p dir="RTL">&bull;&nbsp;&nbsp; إذا كنت تعاني من القرحة أو تاريخ مرضي من الإصابة بالقرحة أو كنت عرضة لحدوث نزيف.</p><p dir="RTL">&bull;&nbsp;&nbsp; إذا كنت تعاني من مرض قائم (نشط) أو شديد في الكبد أو الكلى أو كنت تعاني من قصور القلب الاحتقاني.</p><p dir="RTL">&bull;&nbsp;&nbsp; إذا كنت تعاني من تاريخ مرضي من الإصابات بنوبات الربو الناجمة عن تناول الساليسيلات أو الأدوية الغير الستيرويدية المضادة للالتهابات.</p><p dir="RTL">&bull;&nbsp;&nbsp; إذا كنت تستخدم عقار الميثوتريكسيت بجرعات مقدارها 15 ملغم / أسبوع أو أكثر.</p><p dir="RTL">&bull;&nbsp;&nbsp; إذا كنت في الثلاثة أشهر الأخيرة من الحمل&nbsp; (الثلث الأخير من الحمل)، لأن ذلك قد يتسبب في حدوث مشاكل للطفل الذي لم يولد بعد أو في حدوث مضاعفات أثناء الولادة.</p><p dir="RTL"><strong>تحذيرات واحتياطات</strong></p><p dir="RTL">سوف يطرح عليك طبيبك المعالج العديد من الأسئلة المتعلقة بحالتك الصحية، نمط حياتك والأدوية التي تتناولها قبل أن يصف لك تناول <strong>جوسبرين 81.</strong> من المهم جداً أن تخبر طبيبك المعالج بجميع هذه المعلومات. إذا كنت قد نسيت إخبار طبيبك المعالج حول أي مما يلي، فيجب عليك الاتصال بطبيبك المعالج أو الصيدلي الذي تتعامل معه لتخبره بذلك قبل تناول هذا الدواء (أو أية أدوية):</p><p dir="RTL">&bull;&nbsp;&nbsp; المعاناة من نوبات الربو، ارتفاع ضغط الدم، أمراض القلب، داء النقرس أو غيرها من الحالات الخطرة.</p><p dir="RTL">&bull;&nbsp;&nbsp; كبار السن بعمر 60 سنة وما فوق</p><p dir="RTL">&bull;&nbsp;&nbsp; مشاكل في المعدة مثل حرقة المعدة.</p><p dir="RTL"><strong>تحذير حول نزيف المعدة: الأدوية الحاوية على الأدوية غير الستيرويدية المضادة للالتهابات قد تسبب في حدوث نزيف شديد في المعدة.</strong></p><p dir="RTL">&bull;&nbsp;&nbsp; خلل في وظائف الكبد/الكلى أو خلل في الدورة الدموية القلبية الوعائية (أمراض الأوعية الدموية الكلوية،&nbsp; قصور القلب الاحتقاني، نقص في سوائل الجسم، الخضوع لعملية جراحية كبرى، تخمج (تسمم) الدم أو حدوث نزيف&nbsp; شديد)</p><p dir="RTL">&bull;&nbsp;&nbsp; تاريخ مرضي لحدوث قصور في تجلط الدم</p><p dir="RTL">&bull;&nbsp;&nbsp; المعاناة من من فقر الدم الشديد</p><p dir="RTL">&bull;&nbsp;&nbsp; نقص شديد في نازعات هيدروجين جلوكوز 6 فوسفات</p><p dir="RTL">&bull;&nbsp;&nbsp; محاولة لحدوث حمل، أثناء فترة الحمل أو الرضاعة الطبيعية</p><p dir="RTL">&bull;&nbsp;&nbsp; سيتم الخضوع لعملية جراحية في غضون 5 - 7 أيام</p><p dir="RTL"><strong>تنبيه: </strong>يحتوي هذا الدواء على ما يكفي من المادة الدوائية<strong> </strong>لإيذاء الطفل على نحو&nbsp; خطير.<strong> يجب حفظ&nbsp; هذا الدواء بعيداً عن متناول ومرأى الأطفال. يجب عدم اعطاء هذا الدواء </strong>للأطفال والمراهقين بعمر أقل من 18 سنة والذين يعانون من جديري الماء أو أعراض البرد/الإنفلونزا قبل استشارة الطبيب حول إمكانية حدوث متلازمة راي وهي حالة مرضية نادرة ولكن خطيرة ارتبط حدوثها بتناول أسبرين.</p><p dir="RTL"><strong>تناول</strong><strong> </strong><strong>&nbsp;جوسبرين 81 </strong><strong>بالتزامن مع الأدوية الأخرى</strong></p><p dir="RTL">يجب عليك إخبار طبيبك المعالج إذا كنت تتناول أية أدوية سواء يتم صرفها بموجب وصفة طبية أو دون وصفة طبية بما في ذلك الأدوية التي تعمل على ترقق الدم، الأسيتامينوفين، مضادات التشنجات (الاختلاج)، الأدوية المضادة لداء السكري / أدوية التهاب المفاصل/ والنقرس، الديجوكسين، الجلوكوكورتيكويد، الميثوتركسيت، مثبطات إعادة امتصاص السيروتونين الانتقائية (نوع من مضادات الاكتئاب)، مدرات البول، مثبطات الإنزيمات المحولة للأنجيوتنسين (أدوية لإرتفاع ضغط الدم)، أو إذا كنت تتناول المشروبات الكحولية 3 مرات أو أكثر يومياً.</p><p dir="RTL">يجب عدم تلقي دواء الآيبوبروفين دون استشارة الطبيب المعالج أو الصيدلي، إذا كنت تتلقى <strong>جوسبرين 81 </strong>كعلاج وقائي.</p><p dir="RTL">قد يتداخل استعمال الأدوية الغير الستيرويدية المضادة للالتهابات (على سبيل المثال آيبوبروفين أو نابروكسين) مع الفوائد الوقائية للقلب الخاصة بدواء <strong>جوسبرين 81.</strong> <strong>&nbsp;</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>&nbsp;</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يجب عليك دائماً تناول <strong>جوسبرين 81</strong> بدقة كما أخبرك طبيبك المعالج. يجب عليك استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه مالم تكن متأكداً.</p><p dir="RTL"><strong><u>الجرعة الاعتيادية:</u></strong><u> </u></p><p dir="RTL"><strong>إرشادات الاستعمال (البالغون بعمر 18 سنة وما فوق):</strong>&nbsp; <strong>للعلاج الوقائي على المدى الطويل تحت إشراف الطبيب المعالج:</strong> يوصى بتناول جرعة يتراوح مقدارها ما بين 1 - 4 أقراص يومياً، بناءً على تعليمات الطبيب المعالج. يجب تناول هذا الدواء في نفس الوقت كل يوم. سوف يساعدك ذلك على تذكر تناول الدواء يومياً.&nbsp;</p><p dir="RTL">للحصول على أقصى قدر من الفعالية والفائدة، يجب تناول هذا الدواء في نفس الوقت كل يوم ووفقاً لإرشادات طبيبك المعالج.</p><p dir="RTL">يجب عليك عدم تجاوز المقدار الموصى به من قبل طبيبك من أقراص&nbsp; <strong>جوسبرين 81</strong><strong>.</strong></p><p dir="RTL">قد يخبرك طبيبك المعالج بتناول <strong>جوسبرين 81 </strong>بالتزامن<strong> </strong>مع الأدوية الأخرى، كما قد يوصي طبيبك المعالج بتناول بعض الأطعمة الخاصة وممارسة التمارين الرياضية أو اتباع خطوات أخرى لحماية صحتك.</p><p dir="RTL">تتميز أقراص <strong>جوسبرين 81</strong> بأنها مغلفة تغليفاً معوياً خاصاً، الأمر الذي يسمح لها بالمرور في المعدة دون أن يحدث لها أي تحلل لتصل إلى الأمعاء حيث يتم ذوبانها. إن ذوبان الأقراص في الأمعاء بدلاً عن المعدة يساعد على الحد من خطر حدوث اضطرابات المعدة لذلك يجب عدم سحق أو كسر الأقراص لضمان حماية المعدة.</p><p dir="RTL"><strong><u>أثناء التعرض للنوبة القلبية:</u></strong><strong> </strong>يجب عليك الاتصال بقسم الطوارئ في المستشفى ثم قم بمضغ أو سحق قرصين من <strong>جوسبرين 81.</strong></p><p dir="RTL"><strong>هل يمكن للمريض الاستمرار في تناول جوسبرين 81 لعلاج الصداع /الحمى / ألم التهاب المفاصل؟</strong></p><p dir="RTL">إن <strong>جوسبرين 81</strong> صمم خصيصاً للعلاج الوقائي على المدى الطويل تحت إشراف الطبيب. كما أن جرعته تعد أصغر من&nbsp; المقدار المطلوب لعلاج الصداع والأنواع الأخرى من الألم. إن <strong>جوسبرين 81 </strong>ليس كمسكنات الألم الأخرى على سبيل المثال اسيتامينوفين أو مضادات الالتهاب الغير الستيرويدية على سبيل المثال، آيبوبروفين، نابروكسين. يرجى منك استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه عن المستحضرات الحاوية على الأسبرين الأخرى المتوفرة (أو أي من&nbsp; مسكنات الألم الأخرى على سبيل المثال الاسيتامينوفين، آيبوبروفين، نابروكسين أو الساليسيلات) وعن الجرعة الصحيحة اللازمة لتخفيف الصداع أو الحمى أو ألم المفاصل. يجب عليك دائماً استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه قبل أن تتناول أية أدوية.</p><p dir="RTL"><strong>فرط الجرعة</strong></p><p dir="RTL">يجب عليك الاتصال بالطبيب المعالج أو قسم الطوارئ والإسعافات في المستشفى على الفور إذا كنت تعتقد أنك قمت بتناول جرعة مفرطة من <strong>جوسبرين 81</strong>حتى وإن لم تعاني من أية أعراض.</p><p dir="RTL"><strong>إذا سهوت عن تناول</strong> <strong>جوسبرين 81</strong></p><p dir="RTL">إذا سهوت عن تناول إحدى جرعات <strong>جوسبرين 81،</strong> فلا تقلق إزاء ذلك، تناولها في حال تذكرها. يجب عليك عدم تناول جرعة مضاعفة لتعويض الجرعة التي سهوت عنها ما لم يصف لك الطبيب ذلك.</p><p dir="RTL"><strong>يرجى منك التواصل مع طبيبك المعالج أو الصيدلي الذي تتعامل معه إذا كان لديك أية أسئلة إضافية حول استخدام هذا الدواء. </strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">كما هو عليه الحال مع جميع الأدوية قد ينتج عن تناول <strong>جوسبرين 81</strong> في بعض الأحيان تأثيرات جانبية غير مرغوب فيها.&nbsp; يجب عليك الاتصال بطبيبك المعالج في حال تعرضك لأي مما يلي: غثيان، قيء، تهيج المعدة أو شعور بالألم. في حال لاحظت تعرضك لحدوث كدمات بصورة أكثر سهولة مما كنت عليه قبل البدء في تناول الجرعة اليومية من <strong>جوسبرين 81</strong><strong>.</strong></p><p dir="RTL">&nbsp;قد يؤدي تناول المشروبات الكحولية بصورة يومية أثناء فترة تلقي العلاج اليومي باستخدام <strong>جوسبرين 81</strong> إلى زيادة خطر الإصابة بنزيف الجهاز الهضمي. قد لا تكون هذه جميع التأثيرات الجانبية التي قد يتعرض لها المريض. يرجى منك التواصل مع طبيبك المعالج أو الصيدلي الذي تتعامل معه في حال حدوث أية تأثيرات جانبية غير محتمل حدوثها (غير متوقعة) أثناة فترة تناول <strong>جوسبرين 81.</strong></p><p dir="RTL"><strong>التأثيرات الجانبية الخطيرة ومعدل تكرارها وما ينبغي القيام به تجاه هذه التأثيرات:</strong></p><p dir="RTL">توقف عن تناول هذا الدواء واتصل بطبيبك المعالج على الفور في حال تعرضك لأية تفاعلات تحسسية (طفح جلدي، شرى، حكة، تورم العينين، الوجه، الشفتين اللسان أو الحلق، أزيز وصعوبة التنفس)، نزيف المعدة (الشعور بالضعف، قيء دموي، قيء يشبه حبيبات القهوة، براز مصحوب بخروج دم أحمر اللون، براز أسود اللون أو قطراني، ألم في المعدة لا يتحسن) فقدان السمع ، رنين أو طنين في الأذنين أو نزيف.</p><p dir="RTL"><strong><u>للإبلاغ عن حدوث أية تأثيرات جانبية:</u></strong></p><p dir="RTL">يرجى منك التحدث إلى طبيبك المعالج أو الصيدلي الذي تتعامل معه، في حال حدوث أياً من التأثيرات الجانبية بما في ذلك أية تأثيرات جانبية يحتمل حدوثها ولم يتم ذكرها في هذه النشرة. كما يمكنك الإبلاغ عن التأثيرات الجانبية مباشرة عن طريق:</p><p dir="RTL">&sect;&nbsp;&nbsp; <strong>المملكة</strong><strong> </strong><strong>العربية</strong><strong> </strong><strong>السعودية</strong><strong>:</strong></p><p dir="RTL"><strong>المركز الوطني للتيقظ الدوائي:</strong></p><p dir="RTL">-&nbsp;&nbsp; <strong>مركز الاتصال الموحد:</strong> 19999</p><p dir="RTL">-&nbsp;&nbsp; <strong>البريد الإلكتروني:</strong> &nbsp;npc.drug@sfda.gov.sa</p><p dir="RTL">-&nbsp;&nbsp; <strong>الموقع الإلكتروني:</strong>&nbsp; https://ade.sfda.gov.sa/</p><p dir="RTL">&sect;&nbsp;&nbsp; <strong>دول الخليج العربي الأخرى: </strong></p><p dir="RTL">-&nbsp;&nbsp; الرجاء الاتصال بالجهات الوطنية في كل دولة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">-&nbsp;&nbsp;&nbsp; يحفظ بعيداً عن متناول ومرأى الأطفال.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; يجب عدم تناول <strong>جوسبرين 81</strong> بعد تاريخ انتهاء الصلاحية المذكور على العبوة و الملصق الداخلي.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; يحفظ في درجة حرارة أقل من 30 &ordm;م، في مكان جاف.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; بعد فتح العبوة: يستخدم خلال 30 يوماُ.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; يجب عدم تناول <strong>جوسبرين 81</strong> إذا لاحظت وجود علامات تلف واضحة.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; يجب عدم التخلص من الأدوية عبر المياه المبتذلة (مياه الصرف الصحي) أو النفايات المنزلية. اسأل الصيدلي الذي تتعامل معه عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. ستساعد هذه الإجراءات على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعالة هي أسبرين. يحتوي كل قرص ذي كسوة معوية على 81 ملغم من الأسبرين.</p><p>مواد أخرى: بلورات السليلوز متناهية الصغر، نشا الذرة، &nbsp;كروس كارميلوز الصوديوم، ثاني أكسيد السليكون الغروي، حمض الاستياريك، أوبادراي كلير، أكريل إيز، ستيرات التراي إثيل، ثلاثي إيثيل سترات ، إيثانول 95%، سيميثيكون المضاد للغازات</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تتوفر أقراص <strong>جوسبرين 81</strong> ذات كسوة معوية في عبوات تحتوي كلاً منها على 30 أو 90 قرصاً (في زجاجة البولي ايثيلين عالية الكثافة).</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>&nbsp;</p><p>&quot;الخليج للصناعات الدوائية&quot; جلفار</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            
8/9/2022م

        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Jusprin 81mg, Enteric-coated Tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each enteric-coated tablet contains:

Item No. 	Material Name 	Scale (mg/Tablet)
		
	Active Ingredient:	
1.		Aspirin*                          81.000
                Use: Rhodine 3020	

Inactive Ingredients: 
1- Microcrystalline cellulose (Avicel PH-112)**  20.90
2- Maize starch dried   	7.000
3- Croscarmellose sodium (AcDiSol)	4.000
4- Colloidal Silicon Dioxide (Aerosil 200)	0.500
5. 	Stearic Acid  	                    1.600

For Seal Coating:
Opadry Clear 03K19229 #     2.300
Ethanol 95%  q.s.
Purified water 	q.s


For Enteric Coated:	
Acryl Eze 93A18597 White ##  7.200
Triethyl Citrate $$ 0.700
Simethicone Antifoam M-30$ 0.070
Purified Water **	q.s.
 	Note:  
 	* Based on the assay value of Aspirin, the quantity may be varied.
 	** Qty. of Microcrystalline cellulose (Avicel 112) compensated based on potency calculation of Aspirin 3020 (Crystalline).
 	# 40% extra quantity of Opadry Clear 03K19229 calculated for process loss.
 	## 40% extra quantity of Acryl Eze 93A18597 White calculated for process loss.
 	$$ 40% extra quantity of Triethyl Citrate calculated for process loss.
 	  $ 40% extra quantity of Simethicone Antifoam M-30 calculated for process loss.QTY. based on 30% dispersion. 
For full list of excipients, see section 6.1.


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Enteric-coated Tablets 
Description: White to off-white, round, biconvex, enteric-coated tablets.
Marking: Face one: Plain 
                 Face two: Plain
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Jusprin 81 is </strong><strong>indicated for the following uses, based on its platelet aggregation inhibitory properties:</strong></p><p>&sect; for reducing the risk of vascular mortality in patients with a suspected acute myocardial infarction;</p><p>&sect; For reducing the risk of a <strong>first </strong>non-fatal myocardial infarction in individuals deemed to be at sufficient risk of such an event by their physician.</p><p>-&nbsp;&nbsp; There is no evidence for a reduction in the risk of <strong>first </strong>fatal myocardial infarction.</p><p>-&nbsp;&nbsp; Acetylsalicylic acid does not reduce the risk of either cardiovascular mortality or Aspirin<strong> </strong>strokes, fatal or non-fatal.</p><p>The decrease in the risk of <strong>first </strong>non-fatal myocardial infarction must be assessed against a much smaller but not insignificant increase in the risk of haemorrhagic stroke as well as gastrointestinal bleeding.</p><p>&sect; for reducing the risk of morbidity and death in patients with unstable angina and in those with previous myocardial infarction;</p><p>&sect; For reducing the risk of transient ischemic attacks (TIA) and for secondary prevention of atherothrombotic cerebral infarction.</p><p>&sect; For prophylaxis of venous thromboembolism after total hip replacement.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Jusprin 81 </strong>should preferably be taken after meals, with plenty of liquid.</p><p><strong><u>Dosing Considerations</u></strong></p><p>Please see below for specific dosing instructions for each indication.</p><p><strong><u>Recommended Dose and Dosage Adjustment</u></strong></p><p><strong>Platelet aggregation inhibitor:</strong></p><p><strong>Suspected Acute Myocardial Infarction: </strong>An initial dose of at least 162 mg chewed or crushed to ensure rapid absorption as soon as a myocardial infarction is suspected. The same dose should be given as maintenance over the next 30 days. After 30 days, consider further therapy based on dosage and administration for prevention of recurrent MI (see Prior Myocardial Infarction).</p><p><strong>Prevention of a first non-fatal myocardial infarction: </strong>81 - 325 mg once daily, according to the individual needs of the patient, as determined by the physician.</p><p><strong>Prior Myocardial Infarction or Unstable Angina Pectoris: </strong>81 - 325 mg daily according to the individual needs of the patient, as determined by the physician.</p><p><strong>Transient Ischemic Attack and Secondary Prevention of Atherothrombotic Cerebral</strong></p><p><strong>Infarction: </strong>81 - 325 mg daily according to the individual needs of the patient, as determined by the physician.</p><p><strong>Prophylaxis of Venous Thromboembolism after total hip replacement: </strong>162 - 325mg (of aspirin) daily according to the individual needs of the patient, as determined by the physician.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                	Patients who are hypersensitive to acetylsalicylic acid (aspirin), salicylates, non-steroidal anti-inflammatory drugs (NSAIDs), analgesics, antipyretics or other ingredients in the product or component of the container. For a complete listing, see section 6.1.
	Acute gastrointestinal ulcer
	History of gastrointestinal ulcers
	Hemorrhagic diathesis
	Active or Severe hepatic failure, renal failure, or congestive heart failure
	Patients with a history of asthma induced by the administration of salicylates or substances with a similar action, notably non-steroidal anti-inflammatory drugs;
	Combination with methotrexate at doses of 15 mg/week or more (see section “4.5”).
	Last trimester of pregnancy (see section “4.4”) 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>General</u></strong><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong></p><p>Aspirin is one of the most frequent causes of accidental poisonings in toddlers and infants. Tablets should be kept well out of the reach of children.</p><p>acetylsalicylic acid should be administered cautiously to patients with:</p><p>-&nbsp;&nbsp; uncontrolled hypertension</p><p>-&nbsp;&nbsp; impaired hepatic, renal function or cardiovascular circulation (e.g. renal vascular disease, congestive heart failure, volume depletion, major surgery, sepsis or major haemorrhagic events)</p><p>-&nbsp;&nbsp; a history of bleeding tendencies, significant anemia and/or hypothrombinemia</p><p>-&nbsp;&nbsp; concomitant treatment with anticoagulants (see section &ldquo;4.5&rdquo;)</p><p>-&nbsp;&nbsp; concomitant treatment with NSAIDs, such as ibuprofen and naproxen in patients on an acetylsalicylic acid regimen (see section &ldquo;4.5&rdquo;)</p><p><strong><u>Hypersensitivity</u></strong></p><p>Acetylsalicylic acid may precipitate bronchospasm and induce asthma attacks or other hypersensitivity reactions. Risk factors are present bronchial asthma, hay fever, nasal polyps, or chronic respiratory disease. This applies also for patients showing allergic reactions (e.g. cutaneous reactions, itching, urticaria) to other substances.</p><p><strong><u>Hematologic</u></strong></p><p>Due to effect on platelet aggregation, acetylsalicylic acid may be associated with an increased risk of bleeding. Caution is necessary when salicylates and anticoagulants are prescribed concurrently, as salicylates can depress the concentration of prothrombin in the plasma.</p><p><strong><u>Peri-Operative Considerations</u></strong></p><p>Due to its inhibitory effect on platelet aggregation which persists for several days after administration, acetylsalicylic acid may lead to an increased bleeding tendency during and after surgical operations (including minor surgeries, e.g. dental extractions).</p><p><strong><u>Special Populations</u></strong></p><p><strong>Women attempting to conceive:</strong></p><p>During the first and second trimester of pregnancy, acetylsalicylic acid containing drugs should not be given unless clearly necessary. If acetylsalicylic acid containing drugs are used by a woman attempting to conceive, or during the first and second trimester of pregnancy, the dose should be kept as low as possible and duration of treatment as short as possible.</p><p><strong>Pregnant Women</strong>:</p><p>Acetylsalicylic acid inhibits prostaglandin synthesis. Inhibition of prostaglandin synthesis may adversely affect the pregnancy and/or the embryo/foetal development. Data from epidemiological studies raise concern about an increased risk of miscarriage and of malformations after the use of a prostaglandin synthesis inhibitor in early pregnancy. The risk is believed to increase with dose and duration of therapy. Available data do not support any association between intake of acetylsalicylic acid and an increased risk for miscarriage. For acetylsalicylic acid the available epidemiological data regarding malformation are not consistent, but an increased risk of gastroschisis could not be excluded. A prospective study with exposure in early pregnancy (1<sup>st</sup>-4<sup>th</sup> month) of about 14,800 mother-child pairs has not yielded any association with an elevated rate of malformations.</p><p><strong>During the third trimester of pregnancy, all prostaglandin synthesis inhibitors may expose the foetus to: </strong></p><p>&sect; cardiopulmonary toxicity (with premature closure of the ductus ateriosus and pulmonary hypertension);</p><p>&sect; renal dysfunction, which may progress to renal failure with oligo-hydroamniosis;</p><p><strong>Use of any prostaglandin synthesis inhibitors at the end of pregnancy may expose the mother and the child to:</strong></p><p>&sect; possible prolongation of bleeding time, an anti-aggregating effect which may occur even after very low doses</p><p>&sect; inhibition of uterine contractions resulting in delayed or prolonged labour</p><p>Consequently, acetylsalicylic acid is contraindicated in the third trimester of pregnancy.</p><p><strong>Nursing Women:</strong></p><p>Acetylsalicylic acid and its metabolites pass into breast milk in small quantities. Since no adverse effects on the infant have been observed after occasional use, interruption of breastfeeding is usually unnecessary. However, on regular use or on intake of high doses, breast feeding should be discontinued early.</p><p><strong>Pediatrics</strong></p><p>A possible association between Reye&#39;s syndrome and the use of salicylates has been suggested but not established. Reye&#39;s syndrome has also occurred in many patients not exposed to salicylates. Acetylsalicylic acid should not be used in children and teenagers for viral infections with or without fever without consulting a physician. In certain viral illnesses, especially influenza A, influenza B and varicella, there is a risk of Reye&rsquo;s syndrome, a very rare but possibly life-threatening illness requiring immediate medical action. The risk may be increased when acetylsalicylic acid is given concomitantly; however, no causal relationship has been proven. Should persistent vomiting occur with such diseases; this may be a sign of Reye&rsquo;s syndrome.</p><p><strong>Low Uric Acid Excretion:</strong></p><p>At low doses, acetylsalicylic acid reduces excretion of uric acid. This can trigger gout in patients who already tend to have low uric acid excretion.</p><p><strong>Glucose-6-phosphate dehydrogenase (G6PD) Deficiency:</strong></p><p>In patient suffering from glucose-6-phosphate dehydrogenase (G6PD) deficiency, acetylsalicylic acid may induce hemolysis or haemolytic anemia. Factors that may increase the risk of haemolysis are high dosage, fever, or acute infections.</p><p><strong>Elderly</strong></p><p>In general, acetylsalicylic acid should be used with caution in elderly patients (&ge; 60 years of age), as these patients may be more susceptible to adverse reactions.</p><p><strong><u>Monitoring and Laboratory Tests</u></strong></p><p>Salicylates can produce changes in thyroid function tests.</p><p>Isolated cases of liver function disturbances (transaminases increase) have been described.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Overview</u></strong></p><p>Acetylsalicylic acid should be used with caution with other products that have anticoagulation or antiplatelet effects, as these effects may be potentiated. Drugs that bind to protein binding sites should also be used cautiously since acetylsalicylic acid may displace drugs from their protein binding site.</p><p><strong><u>Contraindicated Interactions</u></strong></p><p><strong>Methotrexate, used at doses of 15 mg/week or more: </strong>Increased hematological toxicity of methotrexate (due to decreased renal clearance of methotrexate by anti-inflammatory agents in general and displacement of methotrexate from its plasma protein binding by salicylates). See section&ldquo;4.3&rdquo;.</p><p><strong>Drug-Drug Interactions</strong></p><p><strong>Methotrexate, used at 15 mg/week or less: </strong>Salicylates may retard the elimination of methotrexate by decreasing renal clearance of methotrexate, displacing methotrexate from protein binding sites, and thereby increasing its hematological toxicity.</p><p><strong>Anti-coagulants, thrombolytics / other inhibitors of platelet aggregation / hemostasis, </strong>e.g. warfarin, heparin: Caution is necessary when salicylates and anticoagulants,<strong> </strong>thrombolytics / other inhibitors of platelet aggregation / hemostasis prescribed concurrently, as salicylates can depress the concentration of prothrombin in the plasma, leading to an increased risk of bleeding.</p><p><strong>Oral hypoglycemics</strong>, e.g. insulin, sulfonylureas: Large doses of salicylates have a hypoglycemic action and may enhance the effect of oral hypoglycemic agents. Diabetics receiving concurrent salicylate and hypoglycemic therapy should be monitored closely: reduction of the sulfonylurea hypoglycemic drug dosage may be necessary.</p><p><strong>Diuretics: </strong>Diuretics in combination with acetylsalicylic acid at higher doses leads to decreased glomerular filtration via decreased prostaglandin synthesis. As a result, sodium excretion may be decreased by salicylate administration.</p><p><strong>Uricosuric Agents: </strong>Salicylates in large doses are uricosuric agents; smaller amounts may depress uric acid clearance and thus decrease the uricosuric effects of other drugs.</p><p><strong>Valproic Acid</strong>: Salicylates may alter valproic acid (VPA) metabolism and may displace VPA from protein binding sites, possibly intensifying the effects of VPA. Caution is recommended when VPA is administered concomitantly with salicylates.</p><p><strong>Glucocorticoids (systemic), except hydrocortisone used as replacement therapy in</strong></p><p><strong>Addison&rsquo;s disease</strong>: Decreased blood salicylate levels during corticosteroid treatment and risk of salicylate overdose after this treatment is stopped via increased elimination of salicylates by corticosteroids.</p><p><strong>Angiotensin Converting Enzyme (ACE) Inhibitors: </strong>The hyponatremic and hypotensive effects of ACE inhibitors <em>may </em>be diminished by the concomitant administration of acetylsalicylic acid due to its indirect effect on the renin-angiotensin conversion pathway (i.e. inhibition of vasodilatory prostaglandins leading to decreased glomerular filtration). The potential interaction may be related to the dose of acetylsalicylic acid (3g/day or more).</p><p><strong>Selective Serotonin Re-uptake Inhibitors (SSRIs): </strong>Increased risk of upper gastrointestinal bleeding due to possibly synergistic effect.</p><p><strong>Digoxin: </strong>Plasma concentrations of digoxin are increased due to a decrease in renal excretion.</p><p><strong>NSAIDS:</strong></p><p><strong>Acetylsalicylic</strong> <strong>acid and other NSAIDs: </strong>The use of other NSAIDs with salicylates at high doses (&ge; 3g/day) may increase the risk of ulcers and gastrointestinal bleeding due to a synergistic effect.</p><p><strong>Ibuprofen: </strong>Ibuprofen can interfere with the anti-platelet effect of low dose acetylsalicylic acid (81-325 mg per day). Long-term daily use of ibuprofen may render acetylsalicylic acid less effective when used for cardioprotection and stroke prevention. To minimize this interaction, regular users of ibuprofen and of low-dose, immediate-release acetylsalicylic acid should take the ibuprofen at least one hour after and 11 hours before the daily acetylsalicylic acid dose. The use of delayed-release (e.g. enteric-coated) acetylsalicylic acid is not recommended when using ibuprofen regularly.</p><p>Healthcare professionals should advise consumers and patients regarding the appropriate concomitant use of ibuprofen and acetylsalicylic acid.</p><p><strong>Naproxen: </strong>Naproxen may attenuate the irreversible platelet inhibition induced by acetylsalicylic acid. Clinical pharmacodynamic data suggest that concurrent (same day) naproxen sodium usage for more than one day consecutively inhibits the effect of low-dose acetylsalicylic acid on platelet activity and this inhibition may persist for up to several days after stopping naproxen sodium therapy. The clinical relevance of this interaction is not known. Treatment with naproxen, in patients with increased cardiovascular risk may limit the cardiovascular protection of acetylsalicylic acid (see section&ldquo;4.4&rdquo;).</p><p>Healthcare professionals should advise consumers and patients regarding the appropriate concomitant use of NSAIDs (i.e. ibuprofen or naproxen) and acetylsalicylic acid.</p><p><strong><u>Drug-Food Interactions</u></strong></p><p>Interactions with food have not been established.</p><p><strong><u>Drug-Herb Interactions</u></strong></p><p>Interactions with herb have not been established.</p><p><strong><u>Drug-Laboratory Interactions</u></strong></p><p>Salicylates can produce changes in thyroid function tests.</p><p><strong><u>Drug-Lifestyle Interactions</u></strong></p><p><strong>Alcohol: </strong>Increased damage to gastrointestinal mucosa and prolonged bleeding time due to additive effects of acetylsalicylic acid and alcohol. Patients having 3 or more alcoholic drinks per day should consult their physician before use.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Women attempting to conceive:</strong></p><p>During the first and second trimester of pregnancy, acetylsalicylic acid containing drugs should not be given unless clearly necessary. If acetylsalicylic acid containing drugs are used by a woman attempting to conceive, or during the first and second trimester of pregnancy, the dose should be kept as low as possible and duration of treatment as short as possible.</p><p><strong>Pregnant Women</strong>:</p><p>Acetylsalicylic acid inhibits prostaglandin synthesis. Inhibition of prostaglandin synthesis may adversely affect the pregnancy and/or the embryo/foetal development. Data from epidemiological studies raise concern about an increased risk of miscarriage and of malformations after the use of a prostaglandin synthesis inhibitor in early pregnancy. The risk is believed to increase with dose and duration of therapy. Available data do not support any association between intake of acetylsalicylic acid and an increased risk for miscarriage. For acetylsalicylic acid the available epidemiological data regarding malformation are not consistent, but an increased risk of gastroschisis could not be excluded. A prospective study with exposure in early pregnancy (1st-4th month) of about 14,800 mother-child pairs has not yielded any association with an elevated rate of malformations.</p><p><strong>During the third trimester of pregnancy, all prostaglandin synthesis inhibitors may expose the foetus to: </strong></p><p>&sect; cardiopulmonary toxicity (with premature closure of the ductus ateriosus and pulmonary hypertension);</p><p>&sect; renal dysfunction, which may progress to renal failure with oligo-hydroamniosis;</p><p><strong>Use of any prostaglandin synthesis inhibitors at the end of pregnancy may expose the mother and the child to: </strong></p><p>&sect; possible prolongation of bleeding time, an anti-aggregating effect which may occur even after very low doses</p><p>&sect; inhibition of uterine contractions resulting in delayed or prolonged labour</p><p>Consequently, acetylsalicylic acid is contraindicated in the third trimester of pregnancy.</p><p><strong>Nursing Women:</strong></p><p>Acetylsalicylic acid and its metabolites pass into breast milk in small quantities. Since no adverse effects on the infant have been observed after occasional use, interruption of breastfeeding is usually unnecessary. However, on regular use or on intake of high doses, breast feeding should be discontinued early.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not stated.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Many adverse reactions due to acetylsalicylic acid ingestion are dose-related. The following is a list of adverse reactions that have been reported in the literature and from both clinical and post-marketing experience.</p><p>Gastrointestinal (the frequency and severity of these adverse effects are dose related): nausea, vomiting, diarrhea, gastrointestinal bleeding and/or ulceration, dyspepsia, heartburn, hematemesis, melena, abdominal pain, and rarely gastrointestinal inflammation.</p><p><u>Bleeding</u>: Due to platelet inhibition, bleedings e.g. perioperative haemorrhage, hematomas, epistaxis, urogenital bleedings, and gingival bleedings may occur.</p><p>Serious bleedings, such as gastrointestinal tract hemorrhages, and cerebral hemorrhages are rare.</p><p>Isolated cases of potentially life threatening bleedings have been reported, especially in patients with uncontrolled hypertension and/or concomitant antihemostatic agents.</p><p><u>Ear:</u> dizziness, tinnitus, vertigo, hearing loss. Dizziness and tinnitus have been reported, which may be indicative of an overdose.</p><p><u>Hematologic:</u> leukopenia, thrombocytopenia, purpura, anemia. Anemia with respective laboratory and clinical signs and symptoms, such as asthenia, pallor, and hypoperfusion is generally caused by bleeding (e.g. occult microbleeding, acute or chronic bleeding). Hemolysis and hemolytic anemia in patients with severe forms of glucose-6-phosphate dehydrogenase (G6PD) deficiency has been reported.</p><p><u>Dermatologic and hypersensitivity:</u> urticaria, pruritus, skin eruptions, asthma, anaphylaxis, edema, nasal congestion and rhinitus. Severe allergic reactions, including anaphylactic shock are very rarely reported.</p><p><u>Miscellaneous:</u> mental confusion, drowsiness, sweating, thirst. Transient hepatic impairment with increase in liver transaminases has very rarely been reported. Renal impairment and acute renal failure have been reported.</p><p>&nbsp;</p><p>&nbsp;</p><p><strong><u>To report any side effect(s): </u></strong></p><p>&middot;&nbsp;&nbsp; <strong>Saudi Arabia: </strong></p><p>The National Pharmacovigilance Centre (NPC):</p><p>- SFDA Call Centre: 19999</p><p>- E-mail: npc.drug@sfda.gov.sa</p><p>- Website: https://ade.sfda.gov.sa/</p><p>&middot;&nbsp;&nbsp; <strong>Other GCC States: </strong></p><p>- Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Mild Overdose or Early Poisoning - burning in the mouth, lethargy, nausea, vomiting, tinnitus, sweating, thirst, tachycardia or dizziness.</p><p>Moderate Overdose - all of the symptoms from mild overdose plus tachypnea, hyperpyrexia, sweating, dehydration, loss of coordination, restlessness, mental confusion.</p><p>Severe Overdose - all of the symptoms from moderate overdose plus hypotension, hallucinations, stupor, hypoglycemia, convulsions, cerebral edema, oliguria, renal failure, cardiovascular failure, coma, hemorrhage, metabolic acidosis, respiratory alkalosis and/or failure.</p><p>Emergency Management:</p><p>1.&nbsp;&nbsp; Immediate transfer to hospital and maintain cardiovascular and respiratory support.</p><p>2.&nbsp;&nbsp; Gastric lavage, administration of activated charcoal,</p><p>3.&nbsp;&nbsp; Check of acid-base balance and correct if necessary.</p><p>4.&nbsp;&nbsp; Alkaline diuresis so as to obtain urine pH between 7.5 and 8 should be considered when plasma salicylate concentration is greater than 500 mg/L (3.6 mmol/L) in adults or 300mg/L (2.2 mmol/L) in children</p><p>5.&nbsp;&nbsp; Hemodialysis should be considered in severe poisoning 800mg/L (5.8 mmol/L) in adults and 700mg/L (5.0 mmol/L) in children, as renal elimination of salicylates may be slow due to the presence of acidic urine and renal failure. Hemodialysis should also be considered if the patient is experiencing severe systemic metabolic acidosis (arterial pH &lt; 7.2), acute renal failure, pulmonary edema or CNS symptoms such as: drowsiness, agitation, coma or convulsions.</p><p>6.&nbsp;&nbsp; Fluid losses should be replaced with hypotonic solution (e.g. half saline) and supplemented with glucose 50 to 100 g/L.</p><p>7.&nbsp;&nbsp; Symptomatic treatment.</p><p><strong>Fatal Dose:</strong> varies from 10 to 30g of acetylsalicylic acid. However, (in one case) 130 g of acetylsalicylic acid was ingested without fatal outcome.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Acetylsalicylic acid interferes with the production of prostaglandins in various organs and tissues through acetylation of the enzyme cyclo-oxygenase. Prostaglandins are themselves powerful irritants and produce headaches and pain on injection in man. Prostaglandins also appear to sensitize pain receptors to other noxious substances such as histamine and bradykinin. By preventing the synthesis and release of prostaglandins in inflammation, acetylsalicylic acid may avert the sensitization of pain receptors.</p><p>The antipyretic activity of acetylsalicylic acid is due to its ability to interfere with the production of prostaglandin E1 in the brain. Prostaglandin E1 is one of the most powerful pyretic agents known.</p><p>The inhibition of platelet aggregation by acetylsalicylic acid is due to its ability to interfere with the production of thromboxane A<sub>2</sub> within the platelet. Thromboxane A<sub>2</sub> is, largely, responsible for the aggregating properties of platelets.</p><p>In vitro studies have shown that acetylsalicylic acid enhances the activity of the Nitric oxide (NO)-cGMP system and heme oxygenase-1 (HO-1) by acting on endothelial NO synthase site.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Absorption:</strong></p><p>When acetylsalicylic acid is taken orally, it is rapidly absorbed from the stomach and proximal small intestine. The gastric mucosa is permeable to the non-ionized form of acetylsalicylic acid, which passes through the stomach wall by a passive diffusion process.</p><p>Optimum absorption of salicylate in the human stomach occurs in the pH range of 2.15 to 4.10.</p><p>Absorption in the small intestine occurs at a significantly faster rate than in the stomach. After an oral dose of 0.65 g acetylsalicylic acid, the plasma acetylsalicylate concentration in man usually reaches a level between 0.6 and 1.0 mg % in 20 minutes after ingestion and drops to 0.2 mg % within an hour. Within the same period of time, half or more of the ingested dose is hydrolyzed to salicylic acid by esterases in the gastrointestinal mucosa and the liver, the total plasma salicylate concentration reaching a peak between one or two hours after ingestion, averaging between 3 and 7 mg %. Many factors influence the speed of absorption of acetylsalicylic acid in a particular individual at a given time; tablet disintegration, solubility, particle size, gastric emptying time, psychological state, physical condition, nature and quantity of gastric contents, etc., all affect absorption.</p><p><strong>Distribution:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong></p><p>Distribution of salicylate throughout most body fluids and tissues proceeds at a rapid rate after absorption. Aside from the plasma itself, fluids which have been found to contain substantial amounts of salicylate after oral ingestion include spinal, peritoneal and synovial fluids, saliva and milk. Tissues containing high concentrations of the drug are the kidney, liver, heart and lungs. Concentrations in the brain are usually low, and are minimal in feces, bile and sweat.</p><p>The drug readily crosses the placental barrier. At clinical concentrations, from 50% to 90% of the salicylate is bound to plasma proteins especially albumin, while acetylsalicylic acid itself is bound to only a very limited extent. However, acetylsalicylic acid has the capacity of acetylating various proteins, hormones, DNA, platelets and hemoglobin, which at least partly explains its wide-ranging pharmacological actions.</p><p><strong>Metabolism:</strong></p><p>The liver appears to be the principal site for salicylate metabolism, although other tissues may also be involved. The three chief metabolic products of acetylsalicylic acid or salicylic acid are salicyluric acid, the ether or phenolic glucuronide and the ester or acyl glucuronide. A small fraction is also converted to gentisic acid and other hydroxybenzoic acids. The half-life of acetylsalicylic acid in the circulation is from 13 to 19 minutes so that the blood level drops quickly after absorption is complete. However, the half-life of the salicylate ranges between 3.5 and 4.5 hours, which means that 50% of the ingested dose leaves the circulation within that time.</p><p><strong>Excretion:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong></p><p>Excretion of salicylates occurs principally via the kidney, through a combination of glomerular filtration and tubular excretion, in the form of free salicylic acid, salicyluric acid, as well as phenolic and acyl glucuronides. Salicylate can be detected in the urine shortly after its ingestion but the full dose requires up to 48 hours for complete elimination. The rate of excretion of free salicylate is extremely variable, reported recovery rates in human urine ranging from 10% to 85%, depending largely on urinary pH. In general, it can be stated that acid urine facilitates reabsorption of salicylate by renal tubules, while alkaline urine promotes excretion of the drug.</p><p>With the administration of 325 mg, elimination of acetylsalicylic acid is linear following a first order kinetics. At high concentrations, elimination half-life increases.</p><p><strong>Special Populations and Conditions:</strong></p><p>Absorption and clearance of salicylates are not affected by gender or age.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not Stated.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellspacing="0" cellpadding="0" style="width:402px"><tbody><tr><td colspan="2" style="vertical-align:top"><p><strong><u>Inactive Ingredients: </u></strong></p><p>1- Microcrystalline cellulose (Avicel PH&nbsp; 112)**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>2- Maize starch dried&nbsp;&nbsp;</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>3- Croscarmellose sodium (AcDiSol)</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>4-Colloidal Silicon Dioxide (Aerosil 200)</p></td></tr><tr><td style="vertical-align:top"><p>5.Stearic&nbsp;acid</p><p><strong><u>For Seal Coating:</u></strong></p><table border="0" cellspacing="0" cellpadding="0" style="width:402px"><tbody><tr><td style="vertical-align:top"><p>1.</p><p>2.</p><p>3.</p></td><td style="vertical-align:top"><p>Opadry Clear 03K19229 #</p><p>Ethanol 95%</p><p>Purified water</p><p><strong><u>For Enteric Coated:</u></strong><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong></p><table border="0" cellspacing="0" cellpadding="0" style="width:402px"><tbody><tr><td style="vertical-align:top"><p>&nbsp;&nbsp;&nbsp;&nbsp; 1.</p><p>&nbsp;&nbsp;&nbsp;&nbsp; 2.</p><p>&nbsp;&nbsp;&nbsp;&nbsp; 3.</p><p>&nbsp;&nbsp;&nbsp;&nbsp; 4.</p></td><td style="vertical-align:top"><p>Acryl Eze 93A18597 White ##</p><p>Triethyl Citrate $$</p><p>Simethicone Antifoam M-30$</p><p>Purified Water **</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp; &nbsp;Qty. of Microcrystalline cellulose (Avicel 112) compensated based on potency calculation of Aspirin 3020 (Crystalline).</p><p>&nbsp; &nbsp; &nbsp; &nbsp; # 40% extra quantity of Opadry Clear 03K19229 calculated for process loss.</p><p>&nbsp; &nbsp; &nbsp; ## 40% extra quantity of Acryl Eze 93A18597 White calculated for process loss.</p><p>&nbsp; &nbsp; &nbsp; $$ 40% extra quantity of Triethyl Citrate calculated for process loss.</p><p>&nbsp; &nbsp; &nbsp; &nbsp; $ 40% extra quantity of Simethicone Antifoam M-30 calculated for process loss.QTY. based on 30% dispersion.</p><p>&nbsp;</p></td></tr></tbody></table></td></tr></tbody></table><table border="0" cellspacing="0" cellpadding="0" style="width:660px"><tbody><tr><td style="vertical-align:top"><p>.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not Applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months from the date of manufacturing. 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&ordm;C, in a dry place</p><p>After Opening: Use within 30 days.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&sect; 30&rsquo;s tablets packed in 40 CC HDPE bottle with silica gel canister, cotton and closed with CRC cap with induction sealing along with a leaflet.</p><p>&sect; 90&rsquo;s tablets packed in 40 CC HDPE bottle with silica gel canister, cotton and closed with CRC cap with induction sealing along with a leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special instructions needed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Gulf Pharmaceutical Industries - Julphar
Digdaga, Airport Street.
Ras Al Khaimah - United Arab Emirates.
P.O. Box: 997
Tel. No.: (9717) 2 461 461
Fax No.: (9717) 2 462 462


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                05. April. 2022
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>